HEOR Publications
HEOR resources
BeiGene is committed to developing transparent, actionable clinical and health economic information.
The publications below have been presented at international meetings and congresses, including ASCO and ISPOR.
Click the boxes below to view the publications.
Real World Evidence of Impact of Atrial Fibrillation on Clinical and Economic Outcomes in Patients With
Chronic Lymphocytic Leukemia
Presented at:
The Hematology/Oncology Pharmacy Association (HOPA) Annual Conference; March 29–April 1, 2023; Phoenix,
AZ
View
Open Insurance Claims Database vs Closed Insurance Claims Database to Support Pharmacovigilance Review
of Potential Safety Events in Patients With B-Cell Malignancies: A Fit-for-Purpose Evaluation
Presented at:
The ICPE 2023 Annual Conference; August 23-27, 2023; Halifax, NS, Canada
View
Literature Review of Statistical Methods Comparisons Through Simulations When Using External Control
Arm for Regulatory or HTA Submissions
Presented at:
ISPOR 2023; May 7-10, 2023; Boston, MA
View
Lessons Learned From Successful Real-World Evidence (RWE) Studies Supporting Regulatory Drug Approvals
Presented at:
ISPOR EU 2022 Annual Meeting; November 6-9, 2022; Virtual
View
Budget Impact Analysis of Zanubrutinib for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia
or Small Lymphocytic Lymphoma in the United States
Presented at:
ISPOR EU 2022 Annual Meeting; November 6-9, 2022; Vienna, Austria
View